RxVantage Acquires onPoint Oncology to Expand Offering to Oncology Practices

RxVantage, the leading digital platform connecting healthcare providers to educational resources and experts from life science companies, today announced the acquisition of onPoint Oncology, the leader in oncology reimbursement data and analytics. The partnership ensures that care teams will have access to onPoint’s unique revenue cycle data and reimbursement insights as well as one-click access to educational resources and expertise from any life science company, all through the free RxVantage digital platform.

Wall Street Corners Cancer Care on Florida’s Paradise Coast

The Florida city of Naples is known for its abundance of white-sand beaches, restaurants, and resorts. But when it comes to cancer care, some residents may find themselves with little choice. A single company, GenesisCare, operates all four of the city’s radiation treatment centers. GenesisCare got its foothold in Naples after buying another chain, 21st Century Oncology, that grew with backing from private equity investors. Throngs of wealthy people hoping to retire on Florida’s Paradise Coast made it plum territory for the business, according to Isaac Vire, a former radiation therapist at 21st Century. “Naples is kind of a cash cow,” he says.

BHI Analysis Reveals Slight Drop in U.S. Breast Cancer Rates from 2016 to 2019

In observance of National Breast Cancer Awareness Month, Blue Health Intelligence® (BHI®) examined breast cancer rates in women between 40 and 64 years of age using four years of national commercial claims data from 2016 through 2019. While the average annual rate of breast cancer decreased slightly by 0.1% during that timeframe, rates in women between ages 45 and 49 increased slightly to 1.2%. In BHI’s recent Report on Breast Cancer, analysis shows that approximately 21 out of every 1,000 females ages 40 to 64 (2.1%) were diagnosed with or treated for breast cancer in 2019. Women between 60 and 64 years of age experienced the highest disease rate at 3.3%.

The US Oncology Network Continues to Grow, Enhancing Community Cancer Care by Welcoming Two More Practices

The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, continues to expand its reach into local communities by welcoming Alliance Cancer Specialists and Northwest Oncology. Alliance Cancer Specialists serves patients in Southeastern Pennsylvania, with 21 board-certified medical oncologists and hematologists, eight advanced practice providers and approximately 160 employees who serve patients and referring physicians in the Delaware Valley from 10 sites of service. Northwest Oncology is an advanced oncology group in Northwest Indiana with eight physicians and a team of more than 40 support staff members who provide medical oncology, hematology and gynecologic oncology services from two locations.

CMS Delays Radiation Oncology Payment Model Following Fierce Opposition from Physician Community

The Centers for Medicare and Medicaid Services has decided to delay the start of its mandatory radiation oncology bundled payment model following fierce opposition from the physician community. CMS had planned to launch the effort on Jan. 1; however, the go-live date will now move to July 1, 2021, Administrator Seema Verma announced Wednesday.

COVID-19 Outbreaks Led to Dangerous Delay in Cancer Diagnoses

A decline in mammograms and other screening procedures after the coronavirus pandemic struck is leading to missed and delayed cancer diagnoses, according to data from insurance claims, lab orders, Medicare billings and oncology-practice records, an emerging pattern that is alarming oncologists. Hundreds of thousands of cancer screenings were deferred after worries about Covid-19 shut down much of the U.S. health-care system starting this spring. Because many cancers can advance rapidly, months without detection could mean fewer treatment options and worse outcomes, including more deaths.

5 Changes That Should be Made in Oncology

COVID-19 is certainly important. But oncologists, people with cancer, and complex ecosystem of cancer care in the U.S. are grappling with other important issues as well — reimbursement, distorted incentives, the implications of the massive amount of data that is available, and, of course, high costs and prices. The following are thoughts from five experts on these challenges and how they might be met.

Remedy Health Media Acquires OBR Oncology

Remedy Health Media (Remedy), a leading digital health platform and portfolio company of Topspin Consumer Partners, today announced the acquisition of OBR (Oncology Business Review), an oncology-focused digital media company that provides news and information resources to oncologists and oncology healthcare professionals (HCPs). OBR is a leading resource for the entire oncology team, reaching an audience of more than 25,000 members daily.

Radiation Oncologists Push Back on New CMS Payment Model

CMS on Friday unveiled a value-based payment model for radiation therapy for cancer patients that will launch Jan. 1, prompting the American Society for Radiation Oncology to call for a delay to avoid “unnecessary chaos” for its members. The bundled payment model, part of a final rule on specialty care models, is expected to save Medicare $230 million over five years. ASTRO contends that requiring radiation oncologists to start the model so soon will force burdensome practice changes and investments while they are grappling with staff shortages and other challenges during the COVID-19 pandemic.

CMS Approves Radiation Oncology Payment Model

CMS’ Center for Medicare & Medicaid Innovation on Friday released its final alternative payment model for cancer patients receiving radiotherapy. The radiation oncology model is supposed to test whether making 90-day bundled payments for radiation therapy maintains or improves the quality of care that Medicare beneficiaries receive and reduces Medicare spending compared to traditional fee-for-service. According to CMS, the pilot will save the federal government $230 million over five years. It kicks off January 1. The agency thinks patients could benefit from fewer treatments and better outcomes under the new payment model.